For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago

Remember the simpler times of the mid-2010s, when you could order a latte or cocktail in California without the option of adding CBD? For Justin Gover, CEO of British drugmaker GW Pharmaceuticals (NASDAQ: GWPH), society?s sudden embrace of cannabidiol (CBD), the other active ingredient found in the cannabis plant, is a trip?though CBD won?t make [?]